Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |